Format

Send to

Choose Destination
Biochem Pharmacol. 2002 Sep;64(5-6):797-803.

Growth signaling in breast cancer cells: outcomes and promises of proteomics.

Author information

1
Laboratoire de Biologie du Développement UPRES-EA 1033, Université de Lille1, Bâtiment SN3, Villeneuve d'Ascq Cedex, France.

Abstract

Methods in functional proteomics are now used to study the intracellular signaling pathways that underlie the development of breast cancer. As shown with fibroblast growth factor-2, the oncogenic/non-coding mRNA H19 and 14-3-3 proteins, proteomics is a powerful approach to identify signaling proteins and to decipher the complex signaling circuitry involved in growth of breast cancer cells. Together with genomics, proteomics is now providing a way to define molecular processes involved in breast cancerogenesis and to identify new therapeutic targets.

PMID:
12213572
[Indexed for MEDLINE]

Supplemental Content

Full text links

Icon for Elsevier Science
Loading ...
Support Center